Ewayan, Rolando .

HRN: 28-49-61  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/12/2026
06/19/2026
IV
2.25g
Q 6
CAP-MR
Rejected 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines